盛京銀行(02066.HK):瀋陽市國資委附屬增持1.67億股公司內資股
格隆匯8月17日丨盛京銀行(02066.HK)發佈公吿,本行近日收到瀋陽市人民政府國有資產監督管理委員會附屬公司東北製藥集團有限責任公司和瀋陽盛京金控投資集團有限公司與恆大集團(南昌)有限公司的股份轉讓相關文件。東藥集團和盛京金控以每股6元人民幣分別受讓恆大南昌所持有的本行137,833,335股內資股及28,833,335股內資股股份,分別約佔本行已發行總股份的1.57%及0.33%。
本行董事會經審議,同意並支持瀋陽市屬重點國有企業在行業監管部門指導下,分次逐步增持本行股份。本行將在瀋陽市人民政府主導下,優化調整股權結構,成為政府的銀行、市民的銀行,迴歸本源、服務實體經濟,在建設數字遼寧、智造強省中發揮金融主力軍作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.